2022 - Research.com Best Female Scientist Award
Her primary scientific interests are in Transplantation, Internal medicine, Surgery, Gastroenterology and Immunology. Her Transplantation research is multidisciplinary, incorporating perspectives in Cord blood and Risk factor. Her study in Surgery is interdisciplinary in nature, drawing from both Thalassemia, Hematology, Anemia and Disease.
Her Gastroenterology research incorporates themes from Survival rate, Chronic myelogenous leukemia, Complication and Regimen. The various areas that Eliane Gluckman examines in her Immunology study include Fanconi anemia and Stem cell. Her Umbilical Cord Blood Transplantation research includes themes of Umbilical cord and Cord Blood Stem Cell Transplantation.
Eliane Gluckman spends much of her time researching Internal medicine, Transplantation, Immunology, Surgery and Gastroenterology. Her research ties Oncology and Internal medicine together. Eliane Gluckman has included themes like Umbilical cord and Cord blood in her Transplantation study.
Her Immunology study frequently links to related topics such as Stem cell. Her Surgery study incorporates themes from Hematology and Anemia. Eliane Gluckman combines subjects such as Busulfan, Survival rate, Regimen, Total body irradiation and Fludarabine with her study of Gastroenterology.
Eliane Gluckman mostly deals with Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Cord blood. Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. Eliane Gluckman works on Transplantation which deals in particular with Graft-versus-host disease.
While the research belongs to areas of Hematopoietic stem cell transplantation, Eliane Gluckman spends her time largely on the problem of Sickle cell anemia, intersecting her research to questions surrounding Bone marrow. The various areas that Eliane Gluckman examines in her Surgery study include Hematology, Univariate analysis and Risk factor. Her research integrates issues of Survival rate, CD34, Stem cell and HLA Mismatch in her study of Cord blood.
Her scientific interests lie mostly in Transplantation, Internal medicine, Surgery, Cord blood and Gastroenterology. Her studies deal with areas such as Survival rate, Transplantation Conditioning and Human leukocyte antigen as well as Transplantation. Her work in Internal medicine tackles topics such as Oncology which are related to areas like Myeloid and Leukemia.
Her Surgery research integrates issues from Hematology, Confidence interval, Cohort and Acute leukemia. The concepts of her Cord blood study are interwoven with issues in HLA Mismatch, Stem cell and Pediatrics. Within one scientific family, she focuses on topics pertaining to Cyclophosphamide under Gastroenterology, and may sometimes address concerns connected to Meta-analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HEMATOPOIETIC RECONSTITUTION IN A PATIENT WITH FANCONI'S ANEMIA BY MEANS OF UMBILICAL-CORD BLOOD FROM AN HLA-IDENTICAL SIBLING
Eliane Gluckman;Hal E. Broxmeyer;Arleen D. Auerbach;Henry S. Friedman.
The New England Journal of Medicine (1989)
Outcome of cord-blood transplantation from related and unrelated donors
Eliane Gluckman;Vanderson Rocha;Agnes Boyer-Chammard;Franco Locatelli.
The New England Journal of Medicine (1997)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo;Emmanuel Payen;Olivier Negre;Gary Wang.
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Vanderson Rocha;John E. Wagner;Kathleen A. Sobocinski;John P. Klein.
The New England Journal of Medicine (2000)
Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia
Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese.
The New England Journal of Medicine (2004)
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.
John M. Goldman;Robert Peter Gale;Mary M. Horowitz;James C. Biggs.
Annals of Internal Medicine (1988)
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Vanderson Rocha;Jacqueline Cornish;Eric L. Sievers;Alexandra Filipovich.
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease
John E Wagner;Michael Steinbuch;Nancy A. Kernan;Hal E. Broxmayer.
The Lancet (1995)
Umbilical cord blood transplantation: the first 25 years and beyond
Karen K. Ballen;Eliane Gluckman;Hal E. Broxmeyer.
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
Philippe Rousselot;Francoise Huguet;Delphine Rea;Laurence Legros.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: